Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 60.24 ($0.74) and traded as low as GBX 57 ($0.70). Tissue Regenix Group shares last traded at GBX 57.03 ($0.70), with a volume of 4,648 shares.
Tissue Regenix Group Trading Up 0.9 %
The firm has a market cap of £42.03 million, a price-to-earnings ratio of -5,900.00 and a beta of 1.61. The company has a debt-to-equity ratio of 35.69, a current ratio of 3.74 and a quick ratio of 2.36. The business has a 50-day moving average of GBX 58.44 and a 200-day moving average of GBX 60.24.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- Insider Trades May Not Tell You What You Think
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Health Care Stocks Explained: Why You Might Want to Invest
- How Do Stock Buybacks Affect Shareholders?
- Stock Dividend Cuts Happen Are You Ready?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
